Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Autori:
Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G; New Technologies for Cervical Cancer Screening Working Group.
Rivista:
Int J Cancer 2020; 147: 1864-1873. doi: 10.1002/ijc.32973. Epub 2020 Mar 27. PMID: 32170961 (IF 5.145)